234 related articles for article (PubMed ID: 33773965)
21. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.
Nison L; Rouprêt M; Bozzini G; Ouzzane A; Audenet F; Pignot G; Ruffion A; Cornu JN; Hurel S; Valeri A; Roumiguie M; Polguer T; Hoarau N; Mérigot de Treigny O; Xylinas E; Matte A; Droupy S; Fais PO; Descazeaud A; Colin P;
World J Urol; 2013 Feb; 31(1):69-76. PubMed ID: 23070533
[TBL] [Abstract][Full Text] [Related]
22. Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.
Rose KM; Murray KS; Labbate C; Woldu S; Linehan J; Jacob J; Kaimakliotis H; Dickstein R; Feldman A; Matin SF; Lotan Y; Humphreys MR; Sexton WJ
Eur Urol Focus; 2023 Sep; 9(5):807-812. PubMed ID: 37059620
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy.
Liu P; Su XH; Xiong GY; Li XS; Zhou LQ
Int Braz J Urol; 2016; 42(6):1129-1135. PubMed ID: 27509369
[TBL] [Abstract][Full Text] [Related]
24. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.
Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G
BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
Katims AB; Say R; Derweesh I; Uzzo R; Minervini A; Wu Z; Abdollah F; Sundaram C; Ferro M; Rha K; Mottrie A; Rosiello G; Simone G; Eun DD; Reese A; Kidd LC; Porter J; Bhattu AS; Gonzalgo ML; Margulis V; Marcus J; Danno A; Meagher M; Tellini R; Mari A; Veccia A; Ghoreifi A; Autorino R; Djaladat H; Mehrazin R
J Urol; 2021 Sep; 206(3):568-576. PubMed ID: 33881931
[TBL] [Abstract][Full Text] [Related]
26. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
[TBL] [Abstract][Full Text] [Related]
29. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
[TBL] [Abstract][Full Text] [Related]
30. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
[TBL] [Abstract][Full Text] [Related]
31. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
32. Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up.
Hasan MN; Rouprêt M; Keeley F; Cracco C; Jones R; Straub M; Traxer O; Osther PJS; Brehmer M
World J Urol; 2019 Nov; 37(11):2289-2296. PubMed ID: 30944969
[TBL] [Abstract][Full Text] [Related]
33. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study.
Chen YT; Yeh HC; Lee HY; Hsieh PF; Chou EC; Tsai YC; Hong JH; Huang CY; Jiang YH; Lee YK; Tseng JS; Yu CC; Chiang BJ; Hsueh TY; Wu CC; Tsai CY
Asian J Surg; 2023 Aug; 46(8):3058-3065. PubMed ID: 37525448
[TBL] [Abstract][Full Text] [Related]
35. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A
World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218
[TBL] [Abstract][Full Text] [Related]
36. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
Giannarini G; Schumacher MC; Thalmann GN; Bitton A; Fleischmann A; Studer UE
BJU Int; 2007 Aug; 100(2):264-8. PubMed ID: 17532855
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
[TBL] [Abstract][Full Text] [Related]
39. Focused UTUC pathways with a risk-stratified approach to diagnostic ureteroscopy: is it the need of the hour? A retrospective cohort analysis.
Parmar K; Hanson M; Mahrous AS; Keeley FX; Timoney AG; Albuheissi S; Rai BP; Philip J
World J Urol; 2024 Feb; 42(1):76. PubMed ID: 38340192
[TBL] [Abstract][Full Text] [Related]
40. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
